PL321779A1 - Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis - Google Patents
Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosisInfo
- Publication number
- PL321779A1 PL321779A1 PL96321779A PL32177996A PL321779A1 PL 321779 A1 PL321779 A1 PL 321779A1 PL 96321779 A PL96321779 A PL 96321779A PL 32177996 A PL32177996 A PL 32177996A PL 321779 A1 PL321779 A1 PL 321779A1
- Authority
- PL
- Poland
- Prior art keywords
- secsual
- kinetosis
- obsessive
- vomiting
- therapy
- Prior art date
Links
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 title 1
- 206010047700 Vomiting Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 201000002859 sleep apnea Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000008673 vomiting Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9514690A FR2742052B1 (fr) | 1995-12-12 | 1995-12-12 | Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports |
| PCT/EP1996/005736 WO1997021439A1 (fr) | 1995-12-12 | 1996-12-11 | Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL321779A1 true PL321779A1 (en) | 1997-12-22 |
Family
ID=9485400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96321779A PL321779A1 (en) | 1995-12-12 | 1996-12-11 | Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0808166A1 (cs) |
| JP (1) | JPH11501051A (cs) |
| CN (1) | CN1177297A (cs) |
| AR (1) | AR004378A1 (cs) |
| AU (1) | AU716665B2 (cs) |
| CA (1) | CA2211161A1 (cs) |
| CZ (1) | CZ255197A3 (cs) |
| ES (1) | ES2134709B1 (cs) |
| FR (1) | FR2742052B1 (cs) |
| HU (1) | HUP9800198A2 (cs) |
| IL (1) | IL121461A0 (cs) |
| NO (1) | NO973589L (cs) |
| PL (1) | PL321779A1 (cs) |
| TR (1) | TR199700794T1 (cs) |
| WO (1) | WO1997021439A1 (cs) |
| ZA (1) | ZA9610457B (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763950B1 (fr) | 1997-06-02 | 2002-09-20 | Esteve Labor Dr | 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique |
| TW526202B (en) * | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
| US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| HK1052705B (en) | 2000-08-14 | 2006-09-29 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazole |
| EP1309591B1 (en) | 2000-08-14 | 2007-01-24 | Ortho-McNeil Pharmaceutical, Inc. | Substituted pyrazoles |
| US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
| EP1309593B1 (en) | 2000-08-14 | 2006-03-15 | Ortho-McNeil Pharmaceutical, Inc. | Substituted pyrazoles |
| US6369032B1 (en) | 2000-09-06 | 2002-04-09 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating allergies |
| EP1715921B1 (en) | 2003-09-25 | 2013-04-24 | Abraxis BioScience, Inc. | Tetrahydroindolone derivatives for treatment of neurological conditions |
| WO2005094827A1 (en) * | 2004-03-30 | 2005-10-13 | Kestrel Pharmaceuticals Inc. | Methods for treating sexual dysfunction |
| AU2006239302B2 (en) | 2005-04-26 | 2011-07-07 | Hypnion, Inc. | Benzisoxazole piperazine compounds and methods of use thereof |
| BRPI0610258A2 (pt) | 2005-04-26 | 2012-09-25 | Hypnion Inc | composto ou um sal farmaceuticamente eficaz do mesmo, composição farmacêutica, e, uso de um composto |
| GB2435827A (en) * | 2006-03-09 | 2007-09-12 | Del Dr Esteve S A Spain Lab | Use of substituted piperazine compounds for the treatment of food related disorders |
| CN115304590B (zh) * | 2022-09-19 | 2024-05-28 | 皮摩尔新药(辽宁)有限公司 | 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
| FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
-
1995
- 1995-12-12 FR FR9514690A patent/FR2742052B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-11 CN CN96192286A patent/CN1177297A/zh active Pending
- 1996-12-11 AU AU13764/97A patent/AU716665B2/en not_active Ceased
- 1996-12-11 PL PL96321779A patent/PL321779A1/xx unknown
- 1996-12-11 CA CA002211161A patent/CA2211161A1/fr not_active Abandoned
- 1996-12-11 JP JP9521756A patent/JPH11501051A/ja active Pending
- 1996-12-11 EP EP96944029A patent/EP0808166A1/fr not_active Withdrawn
- 1996-12-11 HU HU9800198A patent/HUP9800198A2/hu unknown
- 1996-12-11 IL IL12146196A patent/IL121461A0/xx unknown
- 1996-12-11 CZ CZ972551A patent/CZ255197A3/cs unknown
- 1996-12-11 WO PCT/EP1996/005736 patent/WO1997021439A1/fr not_active Ceased
- 1996-12-11 TR TR97/00794T patent/TR199700794T1/xx unknown
- 1996-12-12 ZA ZA9610457A patent/ZA9610457B/xx unknown
- 1996-12-12 AR ARP960105644A patent/AR004378A1/es unknown
- 1996-12-12 ES ES009602700A patent/ES2134709B1/es not_active Expired - Lifetime
-
1997
- 1997-08-04 NO NO973589A patent/NO973589L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ255197A3 (cs) | 1998-01-14 |
| HUP9800198A2 (hu) | 1999-09-28 |
| CN1177297A (zh) | 1998-03-25 |
| ES2134709B1 (es) | 2000-05-16 |
| ES2134709A1 (es) | 1999-10-01 |
| NO973589D0 (no) | 1997-08-04 |
| NO973589L (no) | 1997-10-08 |
| JPH11501051A (ja) | 1999-01-26 |
| FR2742052B1 (fr) | 1998-04-10 |
| CA2211161A1 (fr) | 1997-06-19 |
| TR199700794T1 (xx) | 1997-11-21 |
| ZA9610457B (en) | 1997-06-24 |
| AU716665B2 (en) | 2000-03-02 |
| AU1376497A (en) | 1997-07-03 |
| MX9706133A (es) | 1997-11-29 |
| FR2742052A1 (fr) | 1997-06-13 |
| IL121461A0 (en) | 1998-02-08 |
| EP0808166A1 (fr) | 1997-11-26 |
| WO1997021439A1 (fr) | 1997-06-19 |
| AR004378A1 (es) | 1998-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187513A0 (en) | Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence | |
| AU5200498A (en) | Improved methods and devices for the treatment of airway obstruction, sleep apnea and snoring | |
| AU3309097A (en) | Reduction of skin sensitization in electrotransport drug delivery | |
| AU6897198A (en) | Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions | |
| HUP0004439A3 (en) | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders | |
| AU3497295A (en) | Compositions and methods for the treatment of body weight disorders, including obesity | |
| EP0859637A4 (en) | COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF WEIGHT PROBLEMS, INCLUDING OBESITY | |
| AU2604301A (en) | Tnf inhibitors for the treatment of neurological, retinal and muscular disorders | |
| PL321779A1 (en) | Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis | |
| AU7230196A (en) | Pskh-1 ribozymes and uses in disease treatment | |
| EP0705083A4 (en) | DEVICE AGAINST SNORING AND BREATHSTILL IN SLEEP | |
| PL352330A1 (en) | Derivatives of pyridopyranoazepine, making of same and use of same in therapy | |
| AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
| NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
| PL332643A1 (en) | 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment | |
| LT97135A (en) | Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction | |
| HUP9903886A3 (en) | Azacycloalcane derivatives, preparation thereof and their applications in therapy | |
| HUP9904294A3 (en) | Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain | |
| PL351922A1 (en) | Use of saredutant and its pharmaceutically-permitted salts for making drugs usable in therapy or prevention of any mood disorders, adaptability disorders, or mixed drug-depressive disorders | |
| AU7484596A (en) | Combination therapy for the treatment of diabetes and obesity | |
| AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
| WO1997005864A3 (en) | Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs | |
| AU5386700A (en) | A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases | |
| AU9633998A (en) | Sanitary treatment of a sleeping mattress and associated device | |
| AU6330300A (en) | Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |